Canada Pension Plan Investment Board Cerevel Therapeutics Holdings, Inc. Transaction History
Canada Pension Plan Investment Board
- $96.3 Billion
- Q2 2024
A detailed history of Canada Pension Plan Investment Board transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 113,500 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,500
Previous 135,115
16.0%
Holding current value
$0
Previous $5.71 Million
18.74%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CERE
# of Institutions
242Shares Held
154MCall Options Held
2.19MPut Options Held
3.87M-
Bain Capital Investors LLC Boston, MA65.7MShares$065.37% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.54MShares$04.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.15MShares$00.01% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...